{
  "retracted": false,
  "timestamp": 1538352000000,
  "updates": [
    {
      "timestamp": 1569899446594,
      "identifier": {
        "doi": "10.1007/s10557-018-6834-6"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10557-018-6830-x"
  },
  "journal": "Cardiovascular Drugs and Therapy",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Do Limitations in the Design of PARADIGM-HF Justify the Slow Real World Uptake of Sacubitril/Valsartan (Entresto)?"
}
